As we have mentioned on several occasions,[1]
[2]
[3] Thieme, the publisher of Seminars in Thrombosis and Hemostasis, recently created the Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards in honor of Eberhard F. Mammen (Fig. [1]), and in recognition of his contribution to this field and to the journal that he
both founded and steered for over three decades. These awards began in 2009, under
two categories:
Figure 1 Dr. Eberhard F Mammen (1930–2008).
Most popular article awards: Awarded to the authors of the most popular articles published
in Seminars in Thrombosis and Hemostasis. The awards are determined by the editor
in chief on the basis of user statistics from Thieme eJournals from the preceding
2 years. The awards comprise two major cash prizes of US $1000 plus “open access”
status for these articles thereafter.
Young investigator awards: Best presentation or meeting abstract by a young investigator,
as presented or delivered to an international meeting on a topic related to the fields
of thrombosis and hemostasis, and whose subject matter is determined to be in the
spirit of Dr. Mammen. Up to six cash prizes of US $1000 in any year. Awardees are
expected to prepare a review or other article related to the topic of their presentation
for publication in Seminars in Thrombosis and Hemostasis.
Further details of the awards and the award winners are posted online (http://www.thieme.com/sth), and previous award winner announcements are also available in print.[4]
[5]
[6]
It is therefore with great pleasure that we would like to announce the latest winners
of the Eberhard F. Mammen award for the most popular articles from Seminars in Thrombosis and Hemostasis for the period 2009 to 2010 inclusive, as well as the young investigator awards related
to meetings held in 2010.
REFERENCES
1
Favaloro E J.
Editorial. Welcome to a special issue of Seminars in Thrombosis and Hemostasis—the closing issue for 2008.
Semin Thromb Hemost.
2008;
34
693-696
8
Favaloro E J, McDonald D, Lippi G.
Laboratory investigation of thrombophilia: the good, the bad, and the ugly.
Semin Thromb Hemost.
2009;
35
(7)
695-710
12
Asherson R A, Cervera R, Merrill J T, Erkan D.
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance
and treatment.
Semin Thromb Hemost.
2008;
34
(3)
256-266
15
Lippi G, Franchini M, Favaloro E J, Targher G.
Moderate red wine consumption and cardiovascular disease risk: beyond the “French
paradox.”
Semin Thromb Hemost.
2010;
36
(1)
59-70
17
Tincani A, Bazzani C, Zingarelli S, Lojacono A.
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics,
diagnosis, pathogenesis, and treatment.
Semin Thromb Hemost.
2008;
34
(3)
267-273
19
Harenberg J, Wehling M.
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and
factor IIa.
Semin Thromb Hemost.
2008;
34
(1)
39-57
21
Fareed J, Hoppensteadt D A, Fareed D et al..
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Semin Thromb Hemost.
2008;
34
(1)
58-73
23
Pierangeli S S, Chen P P, Raschi E et al..
Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.
Semin Thromb Hemost.
2008;
34
(3)
236-250
34
Harrison P, Mumford A.
Screening tests of platelet function: update on their appropriate uses for diagnostic
testing.
Semin Thromb Hemost.
2009;
35
(2)
150-157
35
Galli M.
Clinical utility of laboratory tests used to identify antiphospholipid antibodies
and to diagnose the antiphospholipid syndrome.
Semin Thromb Hemost.
2008;
34
(4)
329-334
37
Enjeti A K, Lincz L F, Seldon M.
Detection and measurement of microparticles: an evolving research tool for vascular
biology.
Semin Thromb Hemost.
2007;
33
(8)
771-779
43
Meltzer M E, Doggen C J, de Groot P G, Rosendaal F R, Lisman T.
The impact of the fibrinolytic system on the risk of venous and arterial thrombosis.
Semin Thromb Hemost.
2009;
35
(5)
468-477
44
Peyvandi F, Palla R, Menegatti M, Mannucci P M.
Introduction. Rare bleeding disorders: general aspects of clinical features, diagnosis,
and management.
Semin Thromb Hemost.
2009;
35
(4)
349-355
45
Zuern C S, Lindemann S, Gawaz M.
Platelet function and response to aspirin: gender-specific features and implications
for female thrombotic risk and management.
Semin Thromb Hemost.
2009;
35
(3)
295-306
51
Prechel M, Walenga J M.
The laboratory diagnosis and clinical management of patients with heparin-induced
thrombocytopenia: an update.
Semin Thromb Hemost.
2008;
34
(1)
86-96
54
Coppola A, Tufano A, Cerbone A M, Di Minno G.
Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism.
Semin Thromb Hemost.
2009;
35
(7)
683-694
56
Mezzano D, Quiroga T, Pereira J.
The level of laboratory testing required for diagnosis or exclusion of a platelet
function disorder using platelet aggregation and secretion assays.
Semin Thromb Hemost.
2009;
35
(2)
242-254
57
Hayward C P, Favaloro E J.
Diagnostic evaluation of platelet disorders: the past, the present, and the future.
Semin Thromb Hemost.
2009;
35
(2)
127-130
59
Wong R C, Favaloro E J.
Antiphospholipid antibodies and the antiphospholipid syndrome. I: pathogenesis, clinical
features, diagnosis, and management. Preface.
Semin Thromb Hemost.
2008;
34
(3)
213-218
60
Lippi G, Favaloro E J, Franchini M.
Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench
to bedside.
Semin Thromb Hemost.
2009;
35
(1)
3-8
61
Franchini M, Lippi G, Favaloro E J.
Coagulopathies and thrombosis: usual and unusual causes and associations, part I.
Semin Thromb Hemost.
2009;
35
(3)
257-259
64
Favaloro E J.
Hot topics II: an editorial collection of current issues and controversies in thrombosis
and hemostasis.
Semin Thromb Hemost.
2008;
34
(1)
3-6
